DK1401501T3 - Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens - Google Patents

Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens

Info

Publication number
DK1401501T3
DK1401501T3 DK02747410T DK02747410T DK1401501T3 DK 1401501 T3 DK1401501 T3 DK 1401501T3 DK 02747410 T DK02747410 T DK 02747410T DK 02747410 T DK02747410 T DK 02747410T DK 1401501 T3 DK1401501 T3 DK 1401501T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
oral pharmaceutical
active ingredient
modified release
modified
Prior art date
Application number
DK02747410T
Other languages
English (en)
Inventor
Maria Gabriella Massironi
Original Assignee
Farmatron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmatron Ltd filed Critical Farmatron Ltd
Application granted granted Critical
Publication of DK1401501T3 publication Critical patent/DK1401501T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
DK02747410T 2001-06-26 2002-06-19 Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens DK1401501T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI001337A ITMI20011337A1 (it) 2001-06-26 2001-06-26 Composizioni farmaceutiche orali a rilascio modificato del principio attivo

Publications (1)

Publication Number Publication Date
DK1401501T3 true DK1401501T3 (da) 2006-01-09

Family

ID=11447930

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02747410T DK1401501T3 (da) 2001-06-26 2002-06-19 Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens

Country Status (11)

Country Link
US (1) US7727551B2 (da)
EP (1) EP1401501B1 (da)
JP (1) JP4657601B2 (da)
AT (1) ATE302616T1 (da)
CA (1) CA2451379C (da)
DE (1) DE60205749T2 (da)
DK (1) DK1401501T3 (da)
ES (1) ES2248576T3 (da)
IT (1) ITMI20011337A1 (da)
PT (1) PT1401501E (da)
WO (1) WO2003002151A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US7612112B2 (en) * 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
EP1513504A1 (en) * 2002-06-07 2005-03-16 Ranbaxy Laboratories, Ltd. Sustained release oral dosage forms of gabapentin
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
EP1510208A1 (en) 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
AU2004285535A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
ITMI20032399A1 (it) 2003-12-09 2005-06-10 Zambon Spa Composizione farmaceutica contenente gabapentina.
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
AR052139A1 (es) * 2004-11-17 2007-03-07 Ares Trading Sa Formulaciones de benzotiazol y el uso de las mismas
UY29445A1 (es) * 2005-03-30 2006-10-02 Generex Pharm Inc Composiciones para la transmisión transmucosa oral de la metformina
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
ES2288117B1 (es) * 2006-05-08 2008-12-01 Combino Pharm, S.L. Composicion farmaceutica solida de gabapentina.
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
CA2638240C (en) 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
WO2010120892A2 (en) * 2009-04-14 2010-10-21 The Regents Of The University Of California Improved oral drug devices and drug formulations
ES2649112T3 (es) 2009-05-18 2018-01-10 Sigmoid Pharma Limited Composición que comprende gotas de aceite
CN101703486B (zh) * 2009-11-24 2011-11-09 上海复旦复华药业有限公司 一种氟他胺片剂及其制备方法
US8581001B2 (en) 2010-04-16 2013-11-12 Codman & Shurtleff Metformin-cysteine prodrug
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN102119931B (zh) * 2011-02-21 2013-02-13 寿光富康制药有限公司 一种盐酸二甲双胍缓释片及其制备方法
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201304662D0 (en) * 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
JP6210640B2 (ja) * 2014-06-19 2017-10-11 大原薬品工業株式会社 ホリナートカルシウム含有錠
SI3215127T1 (sl) 2014-11-07 2021-03-31 Sublimity Therapeutics Limited DCU Alpha Innovation Campus Sestavki, obsegajoči ciklosporin
GB201511284D0 (en) * 2015-06-26 2015-08-12 Univ Witwatersrand Jhb An oral pharmaceutical dosage form for the delivery of a peptide and/or protein
JP2017210493A (ja) * 2017-09-08 2017-11-30 大原薬品工業株式会社 ホリナートカルシウム含有錠
IT201800011120A1 (it) 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati
JP2021036003A (ja) * 2020-12-05 2021-03-04 大原薬品工業株式会社 ホリナートカルシウム含有錠
CN117363320B (zh) * 2023-12-07 2024-02-13 黑龙江省鑫博鑫交通科技有限公司 一种公路用融雪剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
TW209174B (da) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
JPH08283146A (ja) * 1995-10-23 1996-10-29 Boehringer Mannheim Gmbh 成形され、圧縮された徐放性単位投薬形態の調製法およびこうして得られた圧縮単位投薬形態
WO1999021534A1 (en) * 1997-10-27 1999-05-06 Merck Patent Gmbh Solid state solutions and dispersions of poorly water soluble drugs
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
JP4790950B2 (ja) * 1999-06-14 2011-10-12 コスモ・テクノロジーズ・リミテッド 制御放出および味感遮蔽経口医薬組成物

Also Published As

Publication number Publication date
CA2451379C (en) 2010-04-06
DE60205749T2 (de) 2006-03-09
ATE302616T1 (de) 2005-09-15
US7727551B2 (en) 2010-06-01
WO2003002151A1 (en) 2003-01-09
US20040213844A1 (en) 2004-10-28
JP4657601B2 (ja) 2011-03-23
EP1401501B1 (en) 2005-08-24
JP2004534833A (ja) 2004-11-18
DE60205749D1 (de) 2005-09-29
ES2248576T3 (es) 2006-03-16
CA2451379A1 (en) 2003-01-09
ITMI20011337A1 (it) 2002-12-26
EP1401501A1 (en) 2004-03-31
ITMI20011337A0 (it) 2001-06-26
PT1401501E (pt) 2005-10-31

Similar Documents

Publication Publication Date Title
DK1401501T3 (da) Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens
DK1448235T3 (da) Orale, farmaceutiske sammensætninger af 5,8,14-triaza-tetracyclo[10.3.1.0(2,11).0(4.9)]-hexadeca-2(11),3,5,7,9-pentaen med kontrolleret frigivelse
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
TR200103575T2 (tr) Sülfonamid ve sülfamid ikameli/katkılı imidazokinolinler
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
BR0212922A (pt) Composições farmacêuticas
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
NO20024891L (no) Farmasöytiske sammensetninger
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
CY1109711T1 (el) Νεα κρυσταλλικη μορφη υδροχλωριουχου λερκανιδιπινης και διαδικασιες για την παρασκευη τους
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
IS8051A (is) Kladríbínefnablöndur til inngjafar um munn
DE602005006278D1 (de) Orale antimikrobielle pharmazeutische zusammensetzungen
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
SE0101932D0 (sv) Pharmaceutical combinations
NO20064808L (no) Orale matrixformuleringer med licarbazepin
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
EA201101119A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
ITMI20011338A0 (it) Composizioni farmaceutiche orali a rilascio immediato del principio attivo
DK1957037T3 (da) Farmaceutisk præparat til nasal anvendelse af fentanyl
ITRM20030363A1 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
DK1648440T3 (da) Halvfaste formuleringer til den orale indgivelse af taxoider
BR0210632A (pt) Tratamento de doença parasìtica